Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 17, Issue 5

September-October 2020

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
Headlines from Washington
Image Challenge
Off the Shelf
President's Column

Ask the Hematologist

Hereditary Hematologic Malignancy Syndromes in Adults: From AYA to AARP

Luke Zurbriggen, MD,Kelcy Smith, MMSc, CGC,Jane E. Churpek, MD, MS

View Articletitled, Hereditary Hematologic Malignancy Syndromes in Adults: From AYA to AARP

Clinical Trials Corner

Factor XI Inhibitors: The Dawn of a New Age of Oral Anticoagulants?

Damon Houghton, MD

View Articletitled, Factor XI Inhibitors: The Dawn of a New Age of Oral Anticoagulants?

S1826: U.S. Intergroup Trial for Advanced-Stage Hodgkin Lymphoma

Alex F. Herrera, MD,Brad Kahl, MD

View Articletitled, S1826: U.S. Intergroup Trial for Advanced-Stage Hodgkin Lymphoma

Diffusion

Variant CURation: A Key Clinical Need Toward CURes in Patients With Inherited Predisposition

Amy DeZern, MD, MHS

View Articletitled, Variant CURation: A Key Clinical Need Toward CURes in Patients With Inherited Predisposition

Three Is Not Better Than One: Intrathecal Triple Therapy Is Not Superior to Intrathecal Methotrexate in Children With HR B-ALL

Lisa M. Niswander, MD, PhD,David T. Teachey, MD

View Articletitled, Three Is Not Better Than One: Intrathecal Triple Therapy Is Not Superior to Intrathecal Methotrexate in Children With HR B-ALL

Catheter-directed Thrombolysis for Iliofemoral DVT: Still No Magic Bullet

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Catheter-directed Thrombolysis for Iliofemoral DVT: Still No Magic Bullet

MRDetect: An Ultrasensitive Solution to Monitor Low Tumor Burden in Liquid Biopsies

Elizabeth D. Lightbody, PhD,Ankit K. Dutta, PhD,Irene M. Ghobrial, MD

View Articletitled, MRDetect: An Ultrasensitive Solution to Monitor Low Tumor Burden in Liquid Biopsies

Learning Lessons About Hemoglobin SC Disease From the Dengue Pandemic

Ifeyinwa (Ify) Osunkwo, MD, MPH

View Articletitled, Learning Lessons About Hemoglobin SC Disease From the Dengue Pandemic

The L-MIND Trial of the Anti-CD19 Antibody Tafasitamab Combined With Lenalidomide for Lower Risk Relapsed DLBCL

Michael Jain, MD, PhD,Frederick Locke, MD

View Articletitled, The L-MIND Trial of the Anti-CD19 Antibody Tafasitamab Combined With Lenalidomide for Lower Risk Relapsed DLBCL

The Sticky Wicket of Undruggable Mutations: Can Targeted Molecular Degradation Help?

Christina Simoglou Karali, MD,Adam Mead, MD, PhD

View Articletitled, The Sticky Wicket of Undruggable Mutations: Can Targeted Molecular Degradation Help?

The VIALE-C Trial: Venetoclax and Low-dose Cytarabine in Older Patients With AML

Bushra Tbakhi, MD,Kristen O’Dwyer, MD

View Articletitled, The VIALE-C Trial: Venetoclax and Low-dose Cytarabine in Older Patients With AML

Does the Immune System Matter in Treatment for AML?

Jacqueline Taylor, MBBS (Hons),Steven Lane, MBBS, PhD, FRACP, FRCPA

View Articletitled, Does the Immune System Matter in Treatment for AML?

Long-Term Effects of Donor-derived Clonal Hematopoiesis: The Gift That Keeps on Giving?

Annette S. Kim, MD, PhD

View Articletitled, Long-Term Effects of Donor-derived Clonal Hematopoiesis: The Gift That Keeps on Giving?

Features

Rethinking Our Work

Laura C. Michaelis, MD

View Articletitled, Rethinking Our Work

When a Viral Pneumonia Becomes a Hematology Problem: Birth of the ASH COVID-19 Research Agenda for Hematologists

Alisa S. Wolberg, PhD,Ross L. Levine, MD

View Articletitled, When a Viral Pneumonia Becomes a Hematology Problem: Birth of the ASH COVID-19 Research Agenda for Hematologists

Headlines from Washington

How COVID-19 Has Changed ASH Advocacy

View Articletitled, How COVID-19 Has Changed ASH Advocacy

Image Challenge

The Dreaded “Other” Category: What’s Different in This Differential??

Moe Takeda, MD,Girish Venkataraman, MD

View Articletitled, The Dreaded “Other” Category: What’s Different in This Differential??

Off the Shelf

Focus on Rare Blood Cancers: From Paucity to Passion

Naveen Pemmaraju, MD

View Articletitled, Focus on Rare Blood Cancers: From Paucity to Passion

President's Column

My Poor Self-Care During the Pandemic

Stephanie J. Lee, MD, MPH

View Articletitled, My Poor Self-Care During the Pandemic

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Hereditary Hematologic Malignancy Syndromes in Adults: From AYA to AARP

Clinical Trials Corner

Factor XI Inhibitors: The Dawn of a New Age of Oral Anticoagulants?

S1826: U.S. Intergroup Trial for Advanced-Stage Hodgkin Lymphoma

Diffusion

Variant CURation: A Key Clinical Need Toward CURes in Patients With Inherited Predisposition

Three Is Not Better Than One: Intrathecal Triple Therapy Is Not Superior to Intrathecal Methotrexate in Children With HR B-ALL

Catheter-directed Thrombolysis for Iliofemoral DVT: Still No Magic Bullet

MRDetect: An Ultrasensitive Solution to Monitor Low Tumor Burden in Liquid Biopsies

Learning Lessons About Hemoglobin SC Disease From the Dengue Pandemic

The L-MIND Trial of the Anti-CD19 Antibody Tafasitamab Combined With Lenalidomide for Lower Risk Relapsed DLBCL

The Sticky Wicket of Undruggable Mutations: Can Targeted Molecular Degradation Help?

The VIALE-C Trial: Venetoclax and Low-dose Cytarabine in Older Patients With AML

Does the Immune System Matter in Treatment for AML?

Long-Term Effects of Donor-derived Clonal Hematopoiesis: The Gift That Keeps on Giving?

Features

Rethinking Our Work

When a Viral Pneumonia Becomes a Hematology Problem: Birth of the ASH COVID-19 Research Agenda for Hematologists

Headlines from Washington

How COVID-19 Has Changed ASH Advocacy

Image Challenge

The Dreaded “Other” Category: What’s Different in This Differential??

Off the Shelf

Focus on Rare Blood Cancers: From Paucity to Passion

President's Column

My Poor Self-Care During the Pandemic

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

Headlines from Washington

Image Challenge

Off the Shelf

President's Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only